Envue Medical Inc (FEED)

$2.46 +0.04 (1.65%)
Market Cap 3.52M
Revenue (ttm) 2.56M
Net Income (ttm) -3.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -144.92%
Debt to Equity Ratio 0.02
Volume 2,757,900
Avg Vol 10,903,361
Day's Range N/A - N/A
Shares Out 1.09M
Stochastic %K 29%
Beta 2.09
Analysts Strong Buy
Price Target $3.50

Company Profile

ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The c...

Industry: Medical Devices
Sector: Healthcare
Phone: (914) 233-3004
Address:
969 Pruitt Ave, Tyler, United States
fj2912
fj2912 Feb. 4 at 2:55 AM
$FEED At this point, this is what is happening with this stock. It is going to go down, but right now the hard to borrow (HTB) rate on Etrade is 139%. The forces that be will keep it propped up for a little while to collect that interest, then it will tank further.
0 · Reply
SqueezeGod
SqueezeGod Feb. 4 at 1:05 AM
In. $FEED is going to pull a $BNAI. 1m float, 20% short interest last report, likely now 40% like BNAI was when it squeezed.
0 · Reply
lecorb
lecorb Feb. 3 at 11:35 PM
$FEED Last update : 9 minutes ago Time Since Last Change Timestamp (UTC) US:FEED Short Shares Availability 1 hour ago 2026-02-03 21:48:39.587 1,000 2 hours ago 2026-02-03 21:16:50.094 600 6 hours ago 2026-02-03 17:31:44.416 1,000 1 day ago 2026-02-02 05:45:49.011 0 2 days ago 2026-02-01 04:43:10.575 15,000 3 days ago 2026-01-31 06:18:46.094 10,000 3 days ago 2026-01-31 02:10:28.936 9,000 4 days ago 2026-01-30 22:17:22.383 15,000 4 days ago 2026-01-30 21:44:38.492 10,000 4 days ago 2026-01-30 21:09:57.381 3,000
0 · Reply
GSP
GSP Feb. 3 at 10:56 PM
$FEED $ENPH
0 · Reply
Guitars7
Guitars7 Feb. 3 at 10:46 PM
$FEED If I’m bearish about a stock I never post bearish. I never mock people or laugh at their calamity. What a bizarre personality to take pleasure in one’s loss. If SP goes down what a cruel thing to laugh. I want what everyone wants….to profit. Can’t hit a home run everyday and no one picks a winning trade everyday but to take pleasure in someone’s loss is disgusting. Life lesson…life is too short to indulge people or let people in your life that are continually negative. It is far more important not to be negative than to be positive. Let that sink in if you can figure that out. Get lost you sad bearish people
1 · Reply
IBOTTheDipAndTheDipWon
IBOTTheDipAndTheDipWon Feb. 3 at 10:12 PM
$FEED Not looking good, feedsters. Two is in your future.
0 · Reply
terryy
terryy Feb. 3 at 9:41 PM
$FEED party time.
0 · Reply
Nedwin513
Nedwin513 Feb. 3 at 9:31 PM
$FEED Catching bids AH
0 · Reply
Berkshireannhathaway1
Berkshireannhathaway1 Feb. 3 at 9:09 PM
$FEED
0 · Reply
_BUBBLES_
_BUBBLES_ Feb. 3 at 8:08 PM
$FEED This really tells you all you need to know.. y’all keep right on shorting.. this thing could potentially ruin your entire year😘
0 · Reply
Latest News on FEED
EXCLUSIVE: ENvue Medical Pushes Reusable OTC Syringes Into Home Care With Distribution Deal

Jan 28, 2026, 8:31 AM EST - 6 days ago

EXCLUSIVE: ENvue Medical Pushes Reusable OTC Syringes Into Home Care With Distribution Deal

ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial

Jan 21, 2026, 8:30 AM EST - 13 days ago

ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial

ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research

Jan 9, 2026, 9:01 AM EST - 25 days ago

ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research

ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK

Dec 18, 2025, 12:30 PM EST - 6 weeks ago

ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK

ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

Dec 15, 2025, 9:00 AM EST - 7 weeks ago

ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED'

Dec 12, 2025, 8:00 AM EST - 7 weeks ago

NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED'

NanoVibronix Issues Letter to Shareholders

Nov 19, 2025, 8:00 AM EST - 2 months ago

NanoVibronix Issues Letter to Shareholders

NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities

Sep 18, 2025, 8:00 AM EDT - 4 months ago

NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities

NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Sep 16, 2025, 3:57 PM EDT - 5 months ago

NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property Portfolio

Sep 15, 2025, 8:00 AM EDT - 5 months ago

NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property Portfolio

NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology

Sep 4, 2025, 8:00 AM EDT - 5 months ago

NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology

NanoVibronix Announces Reverse Stock Split

Aug 8, 2025, 9:00 AM EDT - 6 months ago

NanoVibronix Announces Reverse Stock Split

NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock

Jul 18, 2025, 9:00 AM EDT - 7 months ago

NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock

NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation

Jun 26, 2025, 8:00 AM EDT - 7 months ago

NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation

NanoVibronix's ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement

Jun 24, 2025, 8:00 AM EDT - 8 months ago

NanoVibronix's ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement

ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System

Jun 11, 2025, 8:00 AM EDT - 8 months ago

ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System

NanoVibronix Announces CEO Transition

Jun 4, 2025, 8:38 AM EDT - 8 months ago

NanoVibronix Announces CEO Transition

NanoVibronix Responds to False Post

May 28, 2025, 4:22 PM EDT - 8 months ago

NanoVibronix Responds to False Post

Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures

May 28, 2025, 8:00 AM EDT - 8 months ago

Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures

NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants

May 16, 2025, 4:30 PM EDT - 9 months ago

NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants

NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants

May 15, 2025, 9:00 AM EDT - 9 months ago

NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants

NanoVibronix Announces Results from UroShield™ Case Series

May 12, 2025, 8:50 AM EDT - 9 months ago

NanoVibronix Announces Results from UroShield™ Case Series

NanoVibronix Regains Nasdaq Compliance

Apr 11, 2025, 8:00 AM EDT - 10 months ago

NanoVibronix Regains Nasdaq Compliance

NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia

Apr 1, 2025, 8:00 AM EDT - 11 months ago

NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia

Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal

Mar 14, 2025, 8:00 AM EDT - 11 months ago

Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal

NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.

Feb 14, 2025, 9:43 AM EST - 1 year ago

NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.

NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes

Jan 7, 2025, 8:00 AM EST - 1 year ago

NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes

NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan

Jan 6, 2025, 8:00 AM EST - 1 year ago

NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan

NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement

Dec 11, 2024, 8:00 AM EST - 1 year ago

NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement

NanoVibronix Provides Business Update

Nov 12, 2024, 8:00 AM EST - 1 year ago

NanoVibronix Provides Business Update

NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany

Oct 9, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany

NanoVibronix Signs Letter of Intent with Potential New Distributor

Sep 23, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Signs Letter of Intent with Potential New Distributor

NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders

Aug 21, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders

NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan

May 22, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan

NanoVibronix Issues Letter to Stockholders

May 16, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Issues Letter to Stockholders

NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield

May 14, 2024, 8:30 AM EDT - 1 year ago

NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield

NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract Award

May 1, 2024, 8:00 AM EDT - 1 year ago

NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract Award

NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024

Apr 24, 2024, 1:00 PM EDT - 1 year ago

NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024

NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield

Mar 28, 2024, 8:30 AM EDT - 2 years ago

NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield

NanoVibronix Featured in Your Bladder Health Magazine

Dec 6, 2023, 9:00 AM EST - 2 years ago

NanoVibronix Featured in Your Bladder Health Magazine

NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity

Dec 4, 2023, 9:00 AM EST - 2 years ago

NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity

NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan

Nov 28, 2023, 9:00 AM EST - 2 years ago

NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan

NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1

Nov 7, 2023, 8:30 AM EST - 2 years ago

NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1

NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff

Sep 27, 2023, 8:00 AM EDT - 2 years ago

NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff

NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting

Sep 6, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting

NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Aug 30, 2023, 2:29 PM EDT - 2 years ago

NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

NanoVibronix Cites Positive Results from Independent Testing of UroShield

Aug 30, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Cites Positive Results from Independent Testing of UroShield

NanoVibronix Responds to CMS' Determination for PainShield

Aug 29, 2023, 4:05 PM EDT - 2 years ago

NanoVibronix Responds to CMS' Determination for PainShield

NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff

Aug 28, 2023, 8:30 AM EDT - 2 years ago

NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff

NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus

Aug 23, 2023, 8:45 AM EDT - 2 years ago

NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus

fj2912
fj2912 Feb. 4 at 2:55 AM
$FEED At this point, this is what is happening with this stock. It is going to go down, but right now the hard to borrow (HTB) rate on Etrade is 139%. The forces that be will keep it propped up for a little while to collect that interest, then it will tank further.
0 · Reply
SqueezeGod
SqueezeGod Feb. 4 at 1:05 AM
In. $FEED is going to pull a $BNAI. 1m float, 20% short interest last report, likely now 40% like BNAI was when it squeezed.
0 · Reply
lecorb
lecorb Feb. 3 at 11:35 PM
$FEED Last update : 9 minutes ago Time Since Last Change Timestamp (UTC) US:FEED Short Shares Availability 1 hour ago 2026-02-03 21:48:39.587 1,000 2 hours ago 2026-02-03 21:16:50.094 600 6 hours ago 2026-02-03 17:31:44.416 1,000 1 day ago 2026-02-02 05:45:49.011 0 2 days ago 2026-02-01 04:43:10.575 15,000 3 days ago 2026-01-31 06:18:46.094 10,000 3 days ago 2026-01-31 02:10:28.936 9,000 4 days ago 2026-01-30 22:17:22.383 15,000 4 days ago 2026-01-30 21:44:38.492 10,000 4 days ago 2026-01-30 21:09:57.381 3,000
0 · Reply
GSP
GSP Feb. 3 at 10:56 PM
$FEED $ENPH
0 · Reply
Guitars7
Guitars7 Feb. 3 at 10:46 PM
$FEED If I’m bearish about a stock I never post bearish. I never mock people or laugh at their calamity. What a bizarre personality to take pleasure in one’s loss. If SP goes down what a cruel thing to laugh. I want what everyone wants….to profit. Can’t hit a home run everyday and no one picks a winning trade everyday but to take pleasure in someone’s loss is disgusting. Life lesson…life is too short to indulge people or let people in your life that are continually negative. It is far more important not to be negative than to be positive. Let that sink in if you can figure that out. Get lost you sad bearish people
1 · Reply
IBOTTheDipAndTheDipWon
IBOTTheDipAndTheDipWon Feb. 3 at 10:12 PM
$FEED Not looking good, feedsters. Two is in your future.
0 · Reply
terryy
terryy Feb. 3 at 9:41 PM
$FEED party time.
0 · Reply
Nedwin513
Nedwin513 Feb. 3 at 9:31 PM
$FEED Catching bids AH
0 · Reply
Berkshireannhathaway1
Berkshireannhathaway1 Feb. 3 at 9:09 PM
$FEED
0 · Reply
_BUBBLES_
_BUBBLES_ Feb. 3 at 8:08 PM
$FEED This really tells you all you need to know.. y’all keep right on shorting.. this thing could potentially ruin your entire year😘
0 · Reply
Nedwin513
Nedwin513 Feb. 3 at 7:51 PM
$FEED Moving from 2.33 in a sea of red
0 · Reply
Rambo669
Rambo669 Feb. 3 at 7:45 PM
$FEED On the move boys & girls. 🤑🤑
0 · Reply
Aruns84
Aruns84 Feb. 3 at 7:39 PM
$FEED let’s go!
0 · Reply
DanGucci
DanGucci Feb. 3 at 7:10 PM
$FEED needs volumes of buy pressure to squeeze
0 · Reply
Wweston18
Wweston18 Feb. 3 at 6:43 PM
$FEED we are one announcement from running again.. New Vice President has lots of medical background.. this time we start from a higher price and more watchers of the stock.. lets go
0 · Reply
JustAnotherGuy007
JustAnotherGuy007 Feb. 3 at 6:28 PM
🧪 $CDT Took a starter position. Watching Level 2 closely — seeing the same tape behavior I saw on $FEED before it turned into a 3-day runner. Float / OS: 2.27M / 2.30M Low supply. Interesting demand. Keeping this on radar 👀
0 · Reply
_BUBBLES_
_BUBBLES_ Feb. 3 at 6:26 PM
$FEED Ohh yeah this is a totally normal 5 day long pump n dump.. LMFAO
0 · Reply
Rambo669
Rambo669 Feb. 3 at 5:38 PM
$FEED Gonna be just like PHOE in due time .💲💲
0 · Reply
ggabel7
ggabel7 Feb. 3 at 5:38 PM
$BBAI $BNAI $CISS $INTC $FEED EVTV on the move ya’ll
0 · Reply
BiFrost
BiFrost Feb. 3 at 4:40 PM
$FEED the milk has gone sour - the PAMP is over - last one turn out the lights - thanks for playing.
0 · Reply
victory369
victory369 Feb. 3 at 4:30 PM
$FEED Down again ? 🥹
0 · Reply
ForkMAN
ForkMAN Feb. 3 at 3:08 PM
$FEED Looks interesting. I will take a nibble.
0 · Reply